Aβ-amyloid and Tau Imaging in Dementia

Villemagne, Victor L., Doré, Vincent, Bourgeat, Pierrick, Burnham, Samantha C., Laws, Simon, Salvado, Olivier, Masters, Colin L., Rowe, Christopher C.·2017·Seminars in Nuclear Medicine
DOI 10.1053/j.semnuclmed.2016.09.006

Cites (234)

Items 201–234 of 234

  1. In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer
    Michelle T. Fodero‐Tavoletti, Damian Brockschnieder, Victor L. Villemagne, Lucas Martin, Andrea R. Connor, Andrea Thiele, Mathias Berndt, Catriona McLean, Sabine Krause, Christopher Cleon Rowe et al. · 2012 · Nuclear Medicine and Biology
  2. Combination of Biomarkers: PET [18F]Flutemetamol Imaging and Structural MRI in Dementia and Mild Cognitive Impairment
    Lennart Thurfjell, Jyrki M. P. Lötjönen, Roger Lundqvist, Juha R. Koikkalainen, Hilkka S. Soininen, Gunhild Waldemar, David James Brooks, Rik R. Vandenberghe · 2012 · Neurodegenerative Diseases
  3. [11C]-PIB imaging in patients with Parkinson's disease: Preliminary results
    A. Johansson, Irina Savitcheva, Anton Forsberg · 2007 · Parkinsonism & Related Disorders
  4. Synthesis of 18F-labelled 2-(4′-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB
    Kim Serdons, T. Verduyckt, Dominique Vanderghinste et al. · 2008 · Bioorganic & Medicinal Chemistry Letters
  5. Biomarkers of Alzheimer Disease
    Reisa Anne Sperling, Keith A. Johnson · 2013 · CONTINUUM Lifelong Learning in Neurology
  6. Cortical biochemistry in MCI and Alzheimer disease
    Mark S. Forman, Elliott J. Mufson, Sue E. Leurgans, Domenico Praticò, Sonali C. Joyce, Susan Leight, V. M.-Y. Lee, John Q. Trojanowski · 2007 · Neurology
  7. Toward a multifactorial model of Alzheimer disease
    Martha Storandt, Denise M Head, Anne M. Fagan, David M. Holtzman, John C. Morris · 2012 · Neurobiology of Aging
  8. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer’s disease
    Martin Bauer, Oliver Langer, Peter Dal‐Bianco, Rudolf Karch, M BRUNNER, Aiman Abrahim, Rupert R. Lanzenberger, A HOFMANN, Christian Joukhadar, Paolo Carminati · 2006 · Clinical Pharmacology & Therapeutics
  9. Accuracy of early diagnosis and its impact on the management and course of Alzheimer’s disease
    Carol Y Chang, Daniel H.S. Silverman · 2004 · Expert Review of Molecular Diagnostics
  10. Positron Emission Tomography and Neuropathologic Estimates of Fibrillar Amyloid-β in a Patient With Down Syndrome and Alzheimer Disease
    Marwan Noel Sabbagh · 2011 · Archives of Neurology
  11. Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease
    Victor L. Villemagne, Chris C. Rowe, Stephen Macfarlane, Kathy E. Novakovic, Colin Louis Masters · 2005 · Journal of Clinical Neuroscience
  12. In vivo amyloid imaging in Alzheimer?s disease
    Haris Iqbal Sair, Pudugramam Murali Doraiswamy, Jeffrey R. Petrella · 2004 · Neuroradiology
  13. Amyloid Imaging in Dementias With Atypical Presentation
    D. Wolk, J. Price, Charles Madeira, Judith A. Saxton, B. Snitz, Oscar L. Lopez, Chester A. Mathis, W. Klunk, S. DeKosky · 2012 · Alzheimer's & Dementia
  14. An In Vivo Evaluation of Cerebral Cortical Amyloid with [18F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydrocephalus Patients
    Dean Foster Wong, Abhay Moghekar, Daniele Rigamonti, James Robert Brašić, OLIVIER G. ROUSSET, William D. Willis, Christopher J. Buckley, Adrian P L Smith, Beril Gok, Paul F. Sherwin et al. · 2012 · Molecular Imaging and Biology
  15. Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials
    K. Abigail Andrews, Marc Modat A, Kate Eloise Macdonald, Tom Yeatman, M. Jorge Cardoso, Kelvin K. Leung, Josephine Barnes, Victor L. Villemagne, Christopher Cleon Rowe, Nick C. Fox et al. · 2013 · PLoS ONE
  16. Neurodegenerative diseases neurobiology pathogenesis and therapeutics
    Sarah J. Tabrizi · 2006 · Journal of Neurology Neurosurgery & Psychiatry
  17. Posterior Cortical Atrophy: A Rare Form of Dementia with in vivo Evidence of Amyloid-β Accumulation
    Olli S. Tenovuo, Nina M. Kemppainen, Sargo Aalto · 2008 · Journal of Alzheimer s Disease
  18. The Use of Biomarkers in the Elderly: Current and Future Challenges
    Trey Sunderland, Raquel E. Gur, Steven Edward Arnold · 2005 · Biological Psychiatry
  19. Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview
    John C. Morris, Dennis J. Selkoe · 2011 · Neurobiology of Aging
  20. In Vivo Human Amyloid Imaging
    Jitka Sojkova, Susan M. Resnick · 2011 · Current Alzheimer Research
  21. Neuropathologic Diagnostic Outcomes From a Cohort of Outpatients With Suspected Dementia
    Eric Berg Larson, J. K. Edwards, Ellen S. O’Meara, David Nochlin, S. M. Sumi · 1996 · The Journals of Gerontology Series A
  22. Amyloid PET Ligands for Dementia
    Victor L. Villemagne, Christopher Cleon Rowe · 2010 · PET Clinics
  23. Posterior cortical atrophy with [11C] Pittsburgh compound B accumulation in the primary visual cortex
    Taiki Kambe, Yumiko Motoi, Kenji Ishii, Nobutaka Hattori · 2009 · Journal of Neurology
  24. Amyloid imaging in prodromal Alzheimer's disease
    Rik Ossenkoppele, Bart N.M. van Berckel, Niels D. Prins · 2011 · Alzheimer s Research & Therapy
  25. Role of biomarkers in studies of presymptomatic Alzheimer's disease
    John C. Morris, A. Kimberly, Kimberly A. Quaid, David M. Holtzman, Kejal Kantarci, Jeffrey Alan Kaye, Eric M. Reiman, William Edward Klunk, Eric Siemers · 2005 · Alzheimer s & Dementia
  26. The neuropathology of Alzheimer's disease in the year 2005
    Colin Louis Masters, Konrad T. Beyreuther · 2005 · Cambridge University Press eBooks
  27. Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis
    K. Abigail Andrews, Chris D Frost, Marc Modat A, M. Jorge Cardoso, Chris C. Rowe, Victor L. Villemagne, Nick C. Fox, Sebastien Ourselin A, Jonathan M. Schott, Chris C. Rowe et al. · 2015 · Neurobiology of Aging
  28. Distinct tau PET imaging patterns in typical and atypical Alzheimer’s disease
    Sarazin, Marie, Lagarde, Julien, Bottlaender, Michel · 2016 · Brain
  29. Con: Can neuropathology really confirm the exact diagnosis?
    K. A. Jellinger · 2010 · Alzheimer s Research & Therapy
  30. Abeta Peptide and Alzheimer’s Disease
    Colin James Barrow, David Henry Small · 2006 · Springer eBooks
  31. Pro: Can biomarkers be gold standards in Alzheimer's disease?
    Reisa Anne Sperling, Keith A. Johnson · 2010 · Alzheimer s Research & Therapy
  32. Pro: Can neuropathology really confirm the exact diagnosis?
    Margaret M. Esiri · 2010 · Alzheimer s Research & Therapy
  33. Location, Location, Location
    2007 · Science
  34. Untitled work
    Price · 1999 · 10.1002/1531-8249(199903)45:3